Catalyst Wire Dossier Catalyst Wire Dossier

Ontorpacept

TTI-621 · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ontorpacept, covering 2024-12-11 to 2024-12-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma [Phase 2]

See pricing